GVR Report cover Europe Disposable Syringes Market Size, Share & Trends Report

Europe Disposable Syringes Market Size, Share & Trends Analysis Report By Product (Conventional Syringes, Safety Syringes), By Application (Immunization Injections, Therapeutic Injections), By End-use, By Country, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-040-8
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Report Overview

The Europe disposable syringes market size was valued at USD 2,374.16 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The growth of the Europe disposable syringes industry is attributed due to the increasing prevalence of chronic disorders,rising adoption of safety syringes, growing Hospital-Acquired Infections (HAIs), along with the growing number of surgeries in Europe.

Sweden disposable syringes market size, by product, 2020 - 2030 (USD Million)

Chronic diseases such as urological disorders, cancer, stroke, cardiovascular disorders, chronic renal disease, neurovascular diseases, and others are becoming more common. Non-communicable diseases (NCDs) account for 80% of the disease burden in EU countries and are the primary causes of preventable early deaths. As a result of high blood pressure, obesity, smoking, diabetes, a sedentary lifestyle, and excessive alcohol use, a large percentage of the population today is at risk of developing chronic diseases. For example, the European Chronic Disease Alliance (ECDA) 2021 report includes the following statistical data on the prevalence of certain conditions. Every year, cardiovascular disease (CVD) kills 3.9 million people in Europe and more than 1.8 million people in the EU.

While accounting for only one-eighth of the global population, Europe accounts for almost one-quarter of all cancer diagnoses, with approximately 3.7 million new patients each year. Lung, breast, stomach, liver, colon, and breast cancer are the leading causes of cancer fatalities each year. Moreover, one-fifth of all cancer-related deaths in the EU were caused by lung cancer. Additionally, the need for disposable syringes in various healthcare settings is likely to increase with the growing aging population, a demographic that is more susceptible to chronic illnesses such as diabetes and other lifestyle-related disorders. Due to these key factors, Europe's disposable syringes industry is anticipated to grow in near future.

Needle-stick injuries can happen when you use, disassemble, handle, or dispose of syringes and needles. Due to the high incidence rate of these injuries and their catastrophic consequences, healthcare personnel are encouraged to use syringes with a safety mechanism. This is increasing the need for disposable syringes. According to Eucomed, an organization that promotes the European medical technology industry, over one million needle-stick injuries occur in the region each year. An increase in demand for point-of-care administration and the continued rise of injectable medicines will further drive market growth.

Another driving factor is the need to control the spread of diseases such as HIV. The hazardous syringe disposal practice is one of the reasons for the high incidence rate of HIV. Safe injection procedures help prevent HIV contamination and transmission, which drives the industry. For example, the World Health Organization (WHO) estimated that in 2021, about 38.4 million individuals worldwide were infected with HIV. Similarly, roughly 107,000 people in the European Region were diagnosed with HIV in 2022, with approximately 17,000 in the EU/EEA region.

In addition, unsafe injections can cause abscesses, septicemia, nerve injury, and hemorrhagic fevers. One of the primary factors driving the growth of the safety syringes market is the rise in worries about needle-stick injuries to both patients and healthcare personnel. Sharps Technologies, Inc., for example, patented best-in-class, single-use smart safety syringe solutions in 2022 and announced the completion of its acquisition of Safeguard Medical's syringe production site in Hungary. These latest pharmacological advances are intended to promote safe injection techniques by reducing the possibility of contamination. Thus, increasing demand for disposable syringes in Europe.

Various organizations and market players are meeting the health needs of children and adults in Ukraine and in surrounding countries affected by Russia’s invasion of Ukraine. For instance, in February 2022, Americares supplied over 242 tons of pharmaceuticals and medical supplies worth over USD 48 Million to Ukrainian hospitals and emergency responders, and additional shipments are on the way. These shipments contain trauma kits, IV fluids, wound care supplies, antibiotics, and labor and delivery equipment.

Additionally, Americares awarded grants totaling more than USD 2 million to more than 40 groups in Poland, Romania, Slovakia, and Ukraine that promote health. Additionally, the Americares Medical Outreach program also provided more than USD 3.3 million in donated medicines and medical supplies to finance the travels of 20 volunteer medical teams to Poland, Ukraine, and Romania.

The increasing prevalence of chronic diseases and the rising geriatric population are among the major factors driving the market growth. For instance, as per Statistics Sweden (SCB), the proportion of people aged 80 and above is expected to increase by 50% by 2028.

Product Insights

The safety syringes led the market and accounted for more than 64.06% share of the Europe revenue in 2022.The majority of the time, safety syringes are used to give medications using specialized and standard approaches. Every year, improper injection practices result in over 33,800 HIV infections, 315,000 hepatitis C transmissions, and 1.7 million hepatitis B infections worldwide. Needle-stick injuries are caused by unsafe activities such as multiple usages of a syringe and needle without taking preventative steps as directed by healthcare professionals. Furthermore, traditional disposable syringes protect the recipient but do not ensure patient safety. Such elements are expected to drive segment expansion.

Companies operating in the market are stepping up their efforts to get their products approved so that manufacturers can start mass production. For instance, in June 2021, Terumo Pharmaceutical Solutions, a Terumo Corporation branch, announced that the company will continue to combine injection technologies with modern parenteral therapies to ensure accurate, simpler administration and reduce needle-stick injury. SurGuard3 safety hypodermic needles with disposable syringes, for example, ease administration and help minimize needle-stick injuries. Thus, due to such advancements, Europe's disposable syringes industry is expected to grow during the forecast period.

The conventional syringe is the second leading segment in 2022. Conventional syringes are typically composed of plastic, have visible graduations, and are meant for single use. These syringes provide the advantage of eliminating the risk of infection from blood-borne diseases such as Ebola virus, HIV, and Hepatitis B and C. Yet, less use of disposable traditional syringes and needles in undeveloped European countries due to expensive additional maintenance expenses may stymie category expansion. Several regional governments are launching programs to enhance the usage of conventional disposable syringes and needles to reduce disease transmission in patients, propelling the segment's rise over the forecast period.

End-use Insights

The hospitals led the market and accounted for more than 35.56% share of the Europe revenue in 2022. In terms of disposable syringe volume, hospitals are the main consumers of associated products and services. Furthermore, hospitals are considered key buyers because they have long-term contracts with disposable syringe producers, giving them greater bargaining power and a broader market for product after-sales services. Furthermore, the rising rate of hospitalization due to an increase in trauma cases and other infectious diseases; an increase in the number of well-furnished, well-equipped, and advanced hospitals; an aging population; and an increase in the prevalence of chronic diseases are expected to drive segment growth.

The other segment is anticipated to witness the fastest growth over the forecast period. The other section includes ambulatory surgical centers, medical & academic research centers, and defense forces. Rising healthcare spending can increase the number of research institutes and academics, therefore this area is expected to grow during the projection period. The rising demand for disposable sterile syringes in medical and academic research facilities has resulted from the need for precision and optimum sterility in research operations. Because of the increased knowledge about possible contamination and the increase in research and academic centers, sterility is of the utmost importance in research institutes. Additionally, the FDA and other regulatory agencies have established guidelines to examine research lab sterility and safety policies, which are projected to enhance the market growth.

Application Insights

The therapeutic injections led the market in terms of revenue in 2022. One of the primary drivers propelling the segment is increased awareness of blood donation in Europe. According to the WHO, the average number of blood donations in the European Region ranges from 6 to 67.6 per 1000 people, with Denmark reporting the highest rate. In practically every medical process, from diagnosis to therapy, injections are employed. The high prevalence of diseases such as AIDS, tuberculosis, malaria, and dengue creates a high demand for injections, which are required for diagnosis and treatment.

Europe disposable syringes market share, by application, 2022 (%)

The immunization injections segment is anticipated to witness the fastest growth at a CAGR of 7.05% over the forecast period. Vaccination is primarily a mass activity, which raises the danger of blood-borne pathogen transmission. To avoid needle-stick injuries, numerous syringe and needle uses should be avoided in such instances. Furthermore, the type of injection utilized is determined by the safety, cost, and type of vaccine to be provided. Disposable syringes further eliminate vaccine contamination, improves dose accuracy, and lowers waste caused by many vials.

Country Insights

Germany dominated the market and accounted for over 16.30% share of Europe revenue in 2022. The healthcare system in Germany is based on four major principles: compulsory insurance, solidarity, self-governance, and funding through insurance premiums. In Germany, it is mandatory for everyone to avail insurance, which makes treatments affordable to patients, thereby boosting the demand for proper healthcare services and medicines. Thus, due to such activities disposable syringes market is expected to grow in the near future.

Denmark disposable syringes market is anticipated to witness the fastest growth over the forecast. The disposable syringes market in Denmark is majorly driven by the increasing incidence of chronic diseases and the rising geriatric population. In addition, the Ministry of Health and Prevention through the National Board of Health contributes to health care planning in the form of regulation and guidance regarding the specialized and basic treatment and functions within the hospital services and information on how different forms of treatment should be organized, including coordination of the different levels of treatment. Thus, due to such factors disposable syringes market will grow in Denmark.

Key Companies & Market Share Insights

Manufacturers selling disposable syringes in Europe are increasing their efforts to get their products licensed so that they can begin mass production. Unintentional needle stick injuries in healthcare settings are a major source of worry for manufacturers. In addition, the market players are adopting various strategies, such as partnerships, acquisitions & mergers, product launches, and innovations to strengthen their foothold in the market.

For instance, in June 2021, BD received pandemic orders for 2 billion injectable devices of needles and syringes to support global COVID-19 vaccination operations. This new milestone reflects commitments made by governments around the world, including the U.S, Australia, Brazil, Canada, India, Germany, France, the Philippines, Saudi Arabia, Spain, South Africa, and the U.K., among many others, as well as non-governmental organizations that support vaccine deployment in developing countries. In total, BD is assisting more than 40 countries, non-governmental organizations, and other partners with pandemic orders.Some prominent players in the Europe disposable syringes market include:

  • Cardinal Health

  • B. Braun Melsungen

  • Terumo Corporation

  • ICU Medical, Inc. (Smiths Medical)

  • Nipro Corporation

  • BD

  • Sol-Millennium Medical

  • CODAN Medizinische Geräte GmbH & Co KG

  • Cole-Parmer Instrument Company, LLC. 

  • Henke-Sass, Wolf

  • UltiMed, Inc.

Europe Disposable Syringes Market Report Scope

Report Attribute


Market size value in 2023

USD 2,466.25 million

Revenue forecast in 2030

USD 3.70 billion

Growth Rate

CAGR of 5.75% from 2023 to 2030

Volume in 2023

7,522 million unit

Volume forecast in 2030

11,211 million unit

Growth Rate

CAGR of 5.87% from 2023 to 2030

Base year for estimation


Historical data

2018 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million; volume in million unit, CAGR from 2023 to 2030

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Product, application, end-use, region

Country scope

U.K., Germany, France, Italy, Spain, Norway, Sweden, Denmark

Key companies profiled

Cardinal Health; B. Braun Melsungen; Terumo Corporation; ICU Medical, Inc. (Smiths Medical); Nipro Corporation; BD; Sol-Millennium Medical; CODAN Medizinische Geräte GmbH & Co KG; Cole-Parmer Instrument Company, LLC; Henke-Sass; Wolf; UltiMed, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Europe Disposable Syringes Market Segmentation

This report forecasts volume & revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the Europe disposable syringes market report based on product, application, end-use, and country:

Europe Disposable Syringes Market Report Segmentation

  • Product Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Conventional Syringes

    • Safety Syringes

      • Retractable Safety Syringes

      • Non-retractable Safety Syringes

  • Application Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Immunization Injections

    • Therapeutic Injections

  • End-Use Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

    • Hospital

    • Diagnostic Laboratories

    • Blood Banks

    • Pharmaceutical Industry

    • Veterinary Purposes

    • Others

  • Country Outlook (Volume in Million Unit, Revenue, USD Million; 2018 - 2030)

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Sweden

    • Denmark

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.